Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.

ABSTRACT: The SPIRIT 2013 statement aims to improve the completeness of clinical trial protocol reporting by providing evidence-based recommendations for the minimum set of items to be addressed. This guidance has been instrumental in promoting transparent evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate their impact on health outcomes. The SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence) extension is a new reporting guideline for clinical trial protocols evaluating interventions with an AI component. It was developed in parallel with its companion statement for trial reports: CONSORT-AI (Co

SUBMITTER: Cruz Rivera S 

PROVIDER: S-EPMC7598944 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature